We are live on ! Find out more

Micro Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AMRN icon
1
Amarin Corp
AMRN
$244M
$244M $11.53 1.86%
LCTX icon
2
Lineage Cell Therapeutics
LCTX
$243M
$243M $0.9612 1.75%
PLX icon
3
Protalix BioTherapeutics
PLX
$209M
$209M $2.60 0.76%
ARMP icon
4
Armata Pharmaceuticals
ARMP
$125M
$125M $3.36 0.3%
PTHS icon
5
Pelthos Therapeutics
PTHS
$77.7M
$77.7M $20.29 0.69%
MAIA icon
6
MAIA Biotechnology
MAIA
$66.7M
$66.7M $1.08 1.82%
OSTX icon
7
OS Therapies Inc
OSTX
$59M
$59M $1.26 4.55%
SDEV icon
8
Stablecoin Development Corp
SDEV
$48.1M
$48.1M $0.9507 7.94%
SER icon
9
Serina Therapeutics
SER
$43.9M
$43.9M $1.73 0.58%
ATNM icon
10
Actinium Pharmaceuticals
ATNM
$42.8M
$42.8M $1.36 20.4%
XTNT icon
11
Xtant Medical Holdings
XTNT
$40.7M
$40.7M $0.2900 1.15%
NSRX icon
12
Nasus Pharma
NSRX
$38.7M
$38.7M $3.30 3.77%
NNVC icon
13
NanoViricides
NNVC
$34.2M
$34.2M $1.34 2.9%
CVM icon
14
CEL-SCI Corp
CVM
$30.6M
$30.6M $1.74 2.79%
CPHI icon
15
China Pharma Holdings
CPHI
$29M
$29M $0.6751 4.9%
IBO
16
Impact BioMedical
IBO
$27.2M
$27.2M $3.18 18.7%
MIRA icon
17
MIRA Pharmaceuticals
MIRA
$26.3M
$26.3M $0.6265 0.92%
IGC icon
18
IGC Pharma
IGC
$25.9M
$25.9M $0.2501 1.67%
SCLX icon
19
Scilex Holding
SCLX
$17.7M
$17.7M $2.52 11%
AEON icon
20
AEON Biopharma
AEON
$12.2M
$12.2M $0.2442 5.26%
RGNT icon
21
Regentis Biomaterials
RGNT
$11M
$11M $1.57 5.37%
TOVX icon
22
Theriva Biologics
TOVX
$9.6M
$9.6M $0.2095 0.77%
AIM icon
23
AIM ImmunoTech
AIM
$6.66M
$6.66M $0.1669 0.71%
APUS
24
Apimeds Pharmaceuticals US
APUS
$5.55M
$5.55M $3.68 8.91%
AZTR icon
25
Azitra
AZTR
$4.33M
$4.33M $0.0715 –
1
2

Micro Cap Drug Manufacturers - General Stocks at a Glance

Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.

There are 32 micro cap Drug Manufacturers - General stocks — companies in the Drug Manufacturers - General industry with a market cap under $250M — worth a combined $1.5B.

The largest by market cap are Amarin Corp (AMRN) at $244M, Lineage Cell Therapeutics (LCTX) at $243M and Protalix BioTherapeutics (PLX) at $209M.

Among institutional investors, Amarin Corp (AMRN) drew the most net new fund positions in Q2 2026: 19 funds opened new positions, taking total fund holders up 11 (16%) quarter-over-quarter.

  • Combined market cap: $1.5B across 32 stocks.
  • Micro Cap: market cap under $250M.
  • Largest constituent: Amarin Corp (AMRN), $244M market cap.
  • Most net new fund positions in Q2 2026: Amarin Corp (AMRN), +11 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.